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Introduction {#sec1}
============

In *Drosophila*, maternal factors required for germline development are localized in pole plasm at the posterior pole of the cleavage embryos and are partitioned into the primordial germ cells, called as pole cells ([@bib9]). The pole cells remain at the posterior pole region of the blastoderm embryos and then migrate through embryos to reach the somatic gonads, where they differentiate into functional gamete ([@bib21]). Once pole cells initiate migration, cell cycling is arrested at the G2 phase until they reach the somatic gonads, whereas somatic cells continue to proliferate during embryogenesis ([@bib1], [@bib24], [@bib25], [@bib26], [@bib27]). Although cell-cycle quiescence of germline cells has been reported in many animal species, including *Drosophila* ([@bib1], [@bib6], [@bib10], [@bib12], [@bib22], [@bib25]), its regulatory mechanism is poorly understood.

It has been reported that Nanos (Nos) protein produced from maternal *nos* mRNA inhibits G2/M transition in pole cells by suppressing translation of maternal *Cyclin B* (*CycB*) mRNA ([@bib1], [@bib11]). Lack of maternal Nos activity or CycB protein overexpression is able to drive the quiescent pole cells through mitosis ([@bib1]). However, the prematurely induced mitosis in pole cells is never followed by the S phase, and the pole cells are arrested again at the G1 phase ([@bib1], [@bib25]). This indicates that G1/S transition is also arrested in pole cells and this arrest is independent of Nos activity. Thus, continued cell cycling of pole cells is tightly blocked through multiple cell-cycle checkpoints, or G2/M and G1/S transition. This leads us to speculate that cell-cycle quiescence plays a critical role in germline development.

In this study, we report a mechanism by which G1/S transition is blocked in the migrating pole cells. Our key findings are as follows: (1) In early pole cells, maternal *polar granule component* (*pgc*) represses nucleolus formation and expression of miR-10404 encoded within Nucleolus Organizer Region (NOR). (2) *pgc*-mediated repression of miR-10404 delays degradation of *dacapo* (*dap*) mRNA, which in turn blocks G1/S transition in the migrating pole cells. (3) Derepression of both G1/S and G2/M transition induced by miR-10404 and *CycB* in pole cells causes their failure to migrate properly into the gonads, and their elimination in embryos, implying the importance of the cell-cycle quiescence in *Drosophila* germline development. Considering that cell-cycle quiescence is a common feature of germline development among animals ([@bib18]), our findings provide a basis for understanding the mechanism and significance of cell-cycle quiescence in germline development.

Results and Discussion {#sec2}
======================

miR-10404 Expression Is Inhibited by Maternal *pgc* in Early Pole Cells {#sec2.1}
-----------------------------------------------------------------------

A previous electron microscopic study revealed that newly formed pole cells lack nucleoli at the blastodermal stage, whereas the rest of the somatic nuclei have prominent nucleoli ([@bib16]). To determine the embryonic stage at which pole cells initiate nucleolar formation, we performed immunostaining to detect fibrillarin, a nucleolar marker. We found that nucleoli were undetectable in pole cells at stage 4--5 ([Figures 1](#fig1){ref-type="fig"}A and 1E), at a time when they were observed in all somatic nuclei ([Figure 1](#fig1){ref-type="fig"}A). In pole cells, nucleoli began to form at stage 6--7 ([Figures 1](#fig1){ref-type="fig"}B and E) and became detectable in almost all pole cells by stage 8--9 ([Figure 1](#fig1){ref-type="fig"}E). This is compatible with the observations that pre-rRNA transcription can be faintly observed in newly formed pole cells at stage 4 and is subsequently upregulated in these cells at stage 5 ([@bib23]), whereas it is detected in all somatic nuclei from stage 4 onward ([@bib5], [@bib23]). Thus, nucleolar formation is delayed in pole cells relative to somatic cells and is initiated following pre-rRNA transcription.Figure 1Derepression of Nucleolar Formation and miR-10404 Expression in *pgc*^−^ Pole Cells(A--D) *y w* (A and B) and *pgc*^−^ (C and D) embryos at stage 4 (A and C) and 7 (B and D) were immunostained for fibrillarin, a marker for nucleoli (green), and Vasa, a marker for pole cells (magenta). Scale bars: 10 μm.(E) Percentage of pole cells with nucleoli in *y w* (blue) and *pgc*^−^ (orange) embryos, plotted against embryonic stage. The numbers of *y w* and *pgc*^−^ pole cells examined at each stage are shown in parentheses. Significance was calculated between *y w* and *pgc*^−^ by Fisher\'s exact test (∗: p \< 0.01).(F) Schematic diagram of *mir-10404* gene. *mir-10404* is encoded within the ITS1 region encompassed by the 18S and 5.8S rRNA genes. Nucleolus (gray), *mir-10404* gene (red), and rRNA genes (green) are shown.(G) Relative expression level of miR-10404 in pole cells and whole embryos derived from *pgc/+* (control) and *pgc/pgc* (*pgc*^−^) females. RT-qPCR was performed to detect miR-10404 and *rp49* mRNA in control and *pgc*^−^ whole embryos and in 200 pole cells from control and *pgc*^−^ embryos. The amount of miR-10404 in each sample was normalized against the corresponding amount of *rp49* mRNA and is represented as a log~2~(fold change) relative to the level of miR-10404 in controls. Error bars indicate standard errors of three biological replicates. Significance was calculated between control and *pgc*^−^ by Student\'s t test (n.s.: p \> 0.05, ∗: p \< 0.05).

Next, we sought to determine how nucleolar formation is delayed in pole cells. Given the transient absence of nucleoli in newly formed pole cells, we expected that nucleolar formation is repressed by a maternal factor that is partitioned into pole cells and then degraded rapidly in these cells. Maternal *pgc* mRNA is localized in pole plasm to produce the Pgc peptide only in pole cells ([@bib7], [@bib17]). Pgc peptide remains detectable until stage 5 but rapidly disappears by stage 6 ([@bib7]), when nucleolar formation initiates ([Figure 1](#fig1){ref-type="fig"}E). As expected, in pole cells lacking maternal *pgc* (*pgc*^−^ pole cells), nucleolar formation occurred at stage 4, substantially earlier than in normal (*y w*) pole cells ([Figures 1](#fig1){ref-type="fig"}C--1E). This observation shows that maternal *pgc* inhibits nucleolar formation in newly formed pole cells. Because the Pgc peptide represses RNA polymerase II (RNAP-II) activity in early pole cells ([@bib7], [@bib17]), we assume that RNAP-II-dependent transcription is required to initiate nucleolar formation in pole cells.

Because the nucleolus is the site of ribosome biogenesis, it is plausible that protein synthesis is lower in early pole cells lacking nucleoli relative to that in somatic cells. However, this is not the case: uptake of radioactive amino acids is higher in pole cells than in the somatic region ([@bib29]); the higher rate of translation in pole cells is presumably due to maternally contributed ribosomes.

We noted that the microRNA gene *mir-10404* is encoded within the NOR of the nuclear genome, which encodes rRNAs ([@bib3]). The hairpin sequence for *mir-10404* is located in the internal transcribed spacer 1 region (ITS1) of the NOR ([Figure 1](#fig1){ref-type="fig"}F) and is highly conserved among Dipteran species ([@bib3]). miR-10404 expression was significantly elevated in *pgc*^−^ pole cells but not in *pgc*^−^ whole embryos ([Figure 1](#fig1){ref-type="fig"}G). This observation indicates that miR-10404 expression, as well as nucleolar formation, is repressed in newly formed pole cells by maternal *pgc*.

Repression of miR-10404 Expression Stabilizes *dap* mRNA in Pole Cells {#sec2.2}
----------------------------------------------------------------------

Luciferase assays using cultured cells have revealed that miR-10404 can act *in trans* to downregulate expression of a reporter mRNA carrying its target sequence ([@bib3]); however, the endogenous targets of miR-10404-dependent repression have remained elusive. To identify the endogenous targets, we identified 223 transcripts whose 3′ UTRs contain a sequence complementary to the miR-10404 seed sequence using TargetScanFly ([www.targetscan.org](http://www.targetscan.org){#intref0010}) ([Table S2](#mmc3){ref-type="supplementary-material"}); microRNAs degrade their targets by binding to their 3′ UTRs ([@bib2], [@bib13], [@bib14]). Among the 223 transcripts, we selected *dacapo, red dog mine, Fmr1, β-Mannosidase, claret, raw,* and *abdominal A* as mRNAs whose levels were significantly reduced in *pgc*^−^ pole cells ([Table S3](#mmc4){ref-type="supplementary-material"}), as miR-10404 expression was derepressed in *pgc*^−^ pole cells ([Figure 1](#fig1){ref-type="fig"}G). For further analysis, we focused on *dap*, which was more highly expressed than the other six transcripts in normal pole cells ([Table S3](#mmc4){ref-type="supplementary-material"}). We found that, among the 223 transcripts, the expression of 206 was unaffected in *pgc*^−^ pole cells and only 10 were up-regulated ([Table S3](#mmc4){ref-type="supplementary-material"}). Because miR-10404 was repressed by *pgc* ([Figure 1](#fig1){ref-type="fig"}G), we did not consider these transcripts to be *bona fide* targets of miR-10404-dependent repression in pole cells.

*dap* mRNA is supplied maternally and is distributed throughout early cleavage embryos (stage 1--2) ([@bib15]) ([Figures 2](#fig2){ref-type="fig"}A and 2A\'). Prior to pole cell formation, *dap* mRNA is rapidly degraded in the somatic region and is consequently enriched in pole cells (FlyBase; [www.flybase.org](http://www.flybase.org){#intref0015}) ([@bib15]) ([Figure 2](#fig2){ref-type="fig"}B and B\'). We found that *dap* mRNA remained detectable in pole cells during stage 4--6 ([Figures 2](#fig2){ref-type="fig"}B--D and 2B′--2D\'), but its expression decreased in these cells after stage 7 ([Figures 2](#fig2){ref-type="fig"}E, 2E\', 2F, and 2F\'). Consequently, only a weak signal was detected in pole cells at stage 9 ([Figures 2](#fig2){ref-type="fig"}G and 2G\'). By contrast, in *pgc*^−^ pole cells, the *dap* mRNA signal rapidly decreased at stage 4--6 ([Figures 2](#fig2){ref-type="fig"}H--2K and 2H′--2K′), and the signal was no longer discernible in these cells after stage 7 ([Figures 2](#fig2){ref-type="fig"}L--2N and 2L′--2N\'). These data show that *pgc* is required to stabilize maternal *dap* mRNA in early pole cells.Figure 2Degradation of Maternal *dap* mRNA Is Accelerated in *pgc*^−^ Pole Cells and in Pole Cells of Normal Embryos Injected with miR-10404(A--N and A′--N′) Stage 2 (A, A\', H, and H\'), stage 4 (B, B\', I, and I\'), stage 5 (C, C\', J, and J\'), stage 6 (D, D\', K, and K\'), stage 7 (E, E\', L, and L\'), stage 8 (F, F\', M, and M\'), and stage 9 (G, G\', N, and N\') embryos derived from *y w* (*y w* embryos; A--G and A′--G′) and *pgc*^*Δ1*^*/Df*(*2R*)*X58-7* females (*pgc*^−^ embryos; H--N and H′--N′) were *in situ* hybridized with an RNA probe for *dap* mRNA (green) and immunostained for Vasa (magenta). Pole plasm (A, A\', H, and H\') and pole cells (B--G, B′--G′, I--N, and I′--N′) are shown. Scale bars: 10 μm.(O--T and O′--T′) Stage 2 (O, O\', R, and R\'), stage 4 (P, P\', S, and S\'), and stage 7 embryos (Q, Q\', T, and T\') injected with scrambled miR-10404 \[I(scmiR) embryos; O--Q and O′--Q′\] and miR-10404 \[I(miR) embryos; R--T and R′--T′\] were *in situ* hybridized with an RNA probe for *dap* mRNA (green) and immunostained for Vasa (magenta). Pole plasm (O, O\', R, and R\') and pole cells (P, Q, P\', Q\', S, T, S\', and T\') are shown. Scale bars: 10 μm.

Considering that *dap* is a potential target of miR-10404-dependent RNA degradation, we expected that maternal *pgc* would repress expression of miR-10404, which would otherwise induce degradation of *dap* mRNA in early pole cells. To test this idea, we microinjected miR-10404 into the posterior pole of cleavage embryos at stage 1--2 \[I(miR10404) embryos\]. The maternal *dap* mRNA signal decreased rapidly in pole cells of I(miR10404) embryos ([Figures 2](#fig2){ref-type="fig"}S, 2S\', 2T, and 2T\'), compared with that in pole cells of control embryos injected with a scrambled miR-10404 \[I(scmiR10404) embryos\] ([Figures 2](#fig2){ref-type="fig"}P, 2P\', 2Q, and 2Q\'), although the signal was localized in the pole plasm of I(miR10404) and I(scmiR10404) embryos ([Figures 2](#fig2){ref-type="fig"}O, 2O\', 2R, and 2R\'). These observations show that miR-10404 degrades *dap* mRNA in pole cells. Therefore, we conclude that *pgc*-dependent suppression of miR-10404 expression delays degradation of maternal *dap* mRNA in pole cells, which in turn allows its translation in these cells. Indeed, Dap protein accumulates to high levels in pole cells during gastrulation ([@bib19]).

Suppression of miR-10404 Expression Inhibits G1/S Transition in Pole Cells by Stabilizing *dap* mRNA {#sec2.3}
----------------------------------------------------------------------------------------------------

Because Dap is a member of the p21/p27 family of Cdk inhibitors that blocks the G1/S transition by inhibiting the activity of Cyclin E-Cdk2 complex ([@bib15], [@bib19]), it is possible that suppression of miR-10404 inhibits the G1/S transition in normal pole cells by stabilizing *dap* mRNA. However, we cannot test this idea by supplying miR-10404 to normal pole cells, because normal pole cells are arrested in G2 owing to the lack of Cyclin B (CycB) protein ([@bib1]). To overcome this problem, we used embryos expressing CycB in pole cells. In these embryos, the pole cells are arrested in G1 after mitosis ([@bib1], [@bib25]). We mis-expressed *CycB* mRNA during oogenesis under the control of the *maternal-Gal4* driver. Replacement of the 3′ UTR of *CycB* mRNA with the *nos* 3′ UTR caused maternal *CycB* mRNA to localize to the pole plasm, where it was translated to produce CycB protein in pole cells (CycB embryos) ([Figures S1](#mmc1){ref-type="supplementary-material"}A--S1F and S1A′--S1F\'). These pole cells, but not normal ones, expressed a mitotic marker, a phosphorylated form of histone H3 (PH3), confirming that CycB-expressing pole cells entered mitosis ([Figures S1](#mmc1){ref-type="supplementary-material"}G, S1G\', S1H, and S1H\').

We next asked whether supplying miR-10404 into pole cells would promote their transition from G1 to S in CycB embryos. When miR-10404 was injected into the posterior of CycB embryos \[CycB-I(miR10404) embryos\], pole cells were labeled with 5-ethynyl-2′-deoxyuridine (EdU) ([Figures 3](#fig3){ref-type="fig"}B and 3D), whereas no EdU-labeled pole cells were detectable in CycB embryos injected with scrambled miR-10404 \[CycB-I(scmiR10404) embryos\] ([Figures 3](#fig3){ref-type="fig"}A and 3D). This observation shows that miR-10404 promotes the G1/S transition in pole cells.Figure 3Derepression of the G1/S Transition in Pole Cells of CycB Embryos Injected with miR-10404 and Defects in Their Maintenance and Their Migration into the Gonads(A--C) Pole cells in a CycB-I(scmiR10404) embryo (A), a CycB-I(miR10404) embryo (B), and a CycB-I(miR10404+*dap*) embryo (C) at stage 15 were stained for EdU (green) and immunostained for Vasa (magenta). EdU was incorporated into the nuclei of pole cells within embryos (B). White arrowheads indicate EdU-labeled pole cells. Scale bars: 10 μm.(D) Percentage of EdU-labeled pole cells in CycB-I(scmiR10404), CycB-I(miR10404), and CycB-I(miR10404+*dap*) embryos. The numbers of pole cells examined are shown in parentheses. Significance was calculated by Fisher\'s exact test (∗: p \< 0.01, n.s.: p \> 0.05).(E) Average number of pole cells within and outside the gonad in CycB-I(scmiR10404) (shaded bars), CycB-I(miR10404) (solid bars), and CycB-I(miR10404+*dap*) embryos (hatched bars), which were developing normally to stage 13--15. Numbers of embryos examined are shown in parentheses. Significance was calculated by Student\'s t test (∗: p \< 0.01, ∗∗: 0.01 \< p \< 0.05, n.s.: p \> 0.05). The total number of pole cells within an embryo was also reduced in CycB-I(miR10404) embryos (the average number of pole cells \[AN\] ± standard error \[SE\] = 11 ± 0.78 \[Student\'s t test, p \< 0.01\]), compared with CycB-I(scmiR10404) (AN ± SE = 22.9 ± 1.26) and CycB-I(miR10404+*dap*) embryos (AN ± SE = 19.9 ± 0.80).

Because *dap* mRNA is a target for miR-10404-dependent degradation in pole cells ([Figures 2](#fig2){ref-type="fig"}S, 2S\', 2T, and 2T\'), we expected that derepression of the G1/S transition caused by injection of miR-10404 can be rescued by supplying *dap* mRNA into pole cells. When *dap* mRNA, in which the 5′ and 3′ UTRs were replaced by the corresponding regions from *nos* mRNA, was co-injected with miR-10404 into the posterior of CycB embryos \[CycB-I(miR10404+*dap*) embryos\], the percentage of EdU-labeled pole cells was significantly lower than in CycB-I(miR10404) embryos ([Figures 3](#fig3){ref-type="fig"}C and 3D). These results show that derepression of the G1/S transition in pole cells of CycB-I(miR10404) embryos is rescued by supplying *dap* mRNA. Therefore, we propose that suppression of miR-10404 inhibits the G1/S transition in normal pole cells by stabilizing *dap* mRNA.

The above observations raise the question of whether miR-10404 degrades *dap* mRNA directly. This could be tested by deleting the miR-10404-binding site on *dap* mRNA and examining its effect on G1/S transition in pole cells of CycB-I(miR10404) embryos. Another question is whether miR-10404-dependent cell-cycle regulation through *dap* mRNA degradation is seen in cell types other than pole cells. Although the cell types expressing both miR-10404 and *dap* mRNA remain unclear, we favor the idea that mature miR-10404 is not necessarily produced in all (or almost all) somatic cells with prominent nucleoli. This is based on the fact that mature miR-10404 is produced by a noncanonical miRNA processing pathway that bypasses cleavage by the Drosha/Pasha complex but requires the Dcr-1/loqs complex ([@bib3]), suggesting that miR-10404 is produced in a cell type- and/or stage-specific manner. Future studies are needed to identify the cell types that express both miR-10404 and *dap* mRNA and to test whether miR-10404 overexpression enhances S-phase entry, thereby repressing *dap* expression in these cells.

Derepression of the G1/S Transition Causes Defects in Pole Cell Maintenance and Pole Cell Migration {#sec2.4}
---------------------------------------------------------------------------------------------------

Proper migration of pole cells into the gonads is unaffected by either mis-expression of CycB or the resultant single round of mitosis ([@bib1]). Hence, we asked whether the G1/S transition in pole cells of CycB-I(miR10404) embryos affects proper pole cell migration during embryogenesis. In CycB-I(miR10404) embryos, the number of pole cells within the gonads was significantly reduced, and conversely, pole cell number outside the gonads was elevated, compared with CycB-I(scmiR10404) embryos ([Figure 3](#fig3){ref-type="fig"}E). Furthermore, we found that the total number of pole cells within an embryo (no. of pole cells inside + outside gonads) was also significantly reduced in CycB-I(miR10404) embryos relative to CycB-I(scmiR10404) embryos (see the legend for [Figure 3](#fig3){ref-type="fig"}E). Moreover, the decrease in the total number of pole cells and the inability of pole cells to migrate into the gonads were rescued by injecting *dap* mRNA in CycB-I(miR10404) embryos ([Figure 3](#fig3){ref-type="fig"}E). Since the pole cell defects were almost fully rescued by *dap* alone ([Figure 3](#fig3){ref-type="fig"}E), the rest of the six downstream candidates for miR-10404 in pole cells ([Table S2](#mmc3){ref-type="supplementary-material"}) have limited, if any, contribution to pole cell development in embryos. Based on these data, we propose that repression of the G1/S transition, which results from *dap* stabilization due to the absence of miR-10404, is required in pole cells for their maintenance and migration into the embryonic gonads.

Cell-Cycle Regulation in Pole Cells {#sec2.5}
-----------------------------------

In *Drosophila*, Nos protein produced from maternal *nos* mRNA inhibits the G2/M transition in pole cells by suppressing translation of maternal *CycB* mRNA ([@bib1]). Premature mitosis induced by the lack of maternal *nos* activity or CycB mis-expression is never followed by the S phase ([@bib1], [@bib25]), indicating that the G1/S transition is also inhibited in pole cells. Here, we provide evidence that, in normal pole cells, *pgc*-dependent suppression of miR-10404 expression delays the degradation of *dap* mRNA, repressing the G1/S transition ([Figure 4](#fig4){ref-type="fig"}A).Figure 4A Model Explaining Cell-Cycle Quiescence in Pole Cells, and Derepression of Cell-Cycle Quiescence in *pgc*^−^ Pole Cells(A) Maternal *pgc* represses miR-10404 expression in stage 4 and stage 5 pole cells. Repression of miR-10404 expression delays the degradation of maternal *dap* mRNA to produce Dap protein in pole cells. Dap protein prevents the CycE-Cdk2 complex to block the G1/S transition. On the other hand, maternal *pgc* is also required in pole cells to stabilize maternal *nos* mRNA. Nos protein produced from maternal *nos* mRNA represses the translation of CycB to block the G2/M transition. Consequently, the G2/M and G1/S transition are both blocked in normal pole cells.(B and C) Pole cells in *y w* (B) and *pgc*^−^ embryos (C) at stage 15 were stained for EdU (green) and immunostained for Vasa (magenta). EdU was incorporated in the nuclei of pole cells in *pgc*^−^ (C) embryos. White arrowheads indicate EdU-positive pole cells. Scale bars: 10 μm.(D) Percentage of EdU-labeled pole cells in *y w* and *pgc*^−^ embryos. Numbers of pole cells examined are shown in parentheses. Significance was calculated between *y w* and *pgc*^−^ by Fisher\'s exact test (∗: p \< 0.05).(E and F) Pole cells in *y w* (E) and *pgc*^−^ (F) embryos at stage 13--15 were immunostained for PH3 (green) and Vasa (magenta). PH3 was expressed in the nuclei of pole cells within *pgc*^−^ embryos (F). White arrowheads indicate PH3-positive pole cells. Scale bars: 10 μm.(G) Percentage of PH3-positive pole cells in *y w* and *pgc*^−^ embryos. Numbers of pole cells examined are shown in parentheses. Significance was calculated between *y w* and *pgc*^−^ by Fisher\'s exact test (∗: p \< 0.05).

*pgc*^−^ pole cells exhibit premature loss of maternal *nos* mRNA ([@bib4], [@bib8]), and CycB protein production is derepressed in *pgc*^−^ pole cells owing to the absence of Nos-dependent translational repression of maternal *CycB* mRNA ([@bib4]). In combination with our data, these observations suggest that depletion of maternal *pgc* alone causes derepression of both the G2/M and G1/S transitions in pole cells ([Figure 4](#fig4){ref-type="fig"}A). We found that this is the case; EdU labeling and PH3 expression were both evident in *pgc*^−^ pole cells but not in normal (*y w*) embryos ([Figures 4](#fig4){ref-type="fig"}B--4G). These phenotypes were compatible with those observed in CycB-I(miR10404) embryos ([Figures 3](#fig3){ref-type="fig"}B and 3D).

Moreover, a decrease in the total number of pole cells and an alteration in the ability of pole cells to migrate into embryonic gonads were evident in CycB-I(miR10404) embryos but not in CycB-I(scmiR10404) embryos ([Figure 3](#fig3){ref-type="fig"}E). This suggests that the G1/S transition, but not the G2/M transition, causes defects in pole cell maintenance and pole cell migration, although it remains unknown how the G1/S transition leads to these abnormalities. One possible explanation for this is that the G1/S transition may alter histone modifications in pole cells. In the soma of *Drosophila* embryos, active (H3K4me3) and repressive (H3K27me3) modifications of histone H3 are replaced by unmethylated histone H3 following DNA replication ([@bib20]). Consequently, these modifications are reduced through the S phase but are re-established in the soma by histone-modifying enzymes, thereby maintaining the histone code ([@bib28]). Thus, it is possible that the aberrant DNA replication in early pole cells may cause erasure of chromatin modifications, due to the lack of machinery capable of restoring the normal histone marks. This erasure of histone modifications may alter gene expression in pole cells, which in turn results in their failure to follow proper germline development. Another possible mechanism is that derepression of both the G2/M and G1/S transition, but not the G2/M transition alone, could induce multiple rounds of mitosis in pole cells, resulting in the dilution of regulatory proteins involved in modulating downstream gene expression and/or germline-specific cellular function. Thus, repression of both the G2/M and G1/S transition is required in pole cells to keep the cellular concentration of such proteins high enough for their proper function.

Our observations indicate that the delay in miR-10404 expression is necessary to repress the G1/S transition in early pole cells. Furthermore, our previous observation shows that inhibition of CycB production represses the G2/M transition in pole cells ([@bib1]). These two series of studies indicate that continued cell cycling of pole cells is tightly blocked through multiple cell-cycle checkpoints. Moreover, we found that repression of the G1/S transition is required in pole cells for their proper maintenance and migration into embryonic gonads. Our findings raise questions for future studies: (1) Does derepression of cell cycling alter expression of the genes required for germline development in pole cells? (2) To what extent does cell-cycle quiescence of germline progenitors play conserved roles in proper gamete development in animals? Cell-cycle quiescence has been observed in the germline of sea urchin, frog, nematode, mouse, and fruit fly ([@bib1], [@bib6], [@bib10], [@bib12], [@bib18], [@bib22], [@bib25]). Thus, our findings clarify the widespread role of cell-cycle quiescence in germline development.

Limitations of the Study {#sec2.6}
------------------------

Here, we showed that *pgc*-dependent suppression of miR-10404 expression delays the degradation of *dap* mRNA, repressing G1/S transition in normal pole cells. However, we did not examine experimentally whether miR-10404 degrades *dap* mRNA via direct binding to the *dap* 3′ UTR and whether repression of G1/S transition is relevant to germline development even in the presence of G2/M arrest. Furthermore, it remains unclear whether miR-10404-dependent cell-cycle regulation through *dap* mRNA degradation occurs in cell types other than pole cells. Future studies should seek to clarify these issues.

Methods {#sec3}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Data and Code Availability {#appsec1}
==========================

The accession number for the all RNA-seq data reported in this paper is DNA Data Bank of Japan (DDBJ): DRA009066.
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